World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
78
Citations
24111
World Ranking
1268
National Ranking
84

Overview

Richard J. Colonno is affiliated with Bristol-Myers Squibb in Germany and has contributed extensively to medical research, primarily within the fields of Medicine and Hepatology. Their work spans subfields including Hepatology, Epidemiology, Molecular Biology, Infectious Diseases, and Virology.

Their research focuses on topics related to Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Hepatitis Viruses Studies and Epidemiology, RNA Interference and Gene Delivery, HIV/AIDS drug development and treatment, and HIV Research and Treatment.

Colonno has published in several prominent scientific venues. Frequent publication venues include:

  • Journal of Hepatology
  • Hepatology
  • Antimicrobial Agents and Chemotherapy
  • Journal of Viral Hepatitis
  • Antiviral Research

Notable recent papers authored or co-authored by Colonno include:

  • "Rapid Turnover of Hepatitis B Virus Covalently Closed Circular DNA Indicated by Monitoring Emergence and Reversion of Signature-Mutation in Treated Chronic Hepatitis B Patients" (2020), Hepatology
  • "Preclinical Profile and Characterization of the Hepatitis B Virus Core Protein Inhibitor ABI-H0731" (2020), Antimicrobial Agents and Chemotherapy
  • "Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection" (2022), Journal of Hepatology
  • "Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection" (2022), Journal of Hepatology
  • "Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-positive chronic hepatitis B infection in a long-term extension study" (2020), Journal of Hepatology

Colonno has collaborated frequently with several researchers, including:

  • Qi Huang
  • Tuan Nguyen
  • Edward Gane
  • Ran Yan
  • Steven Knox

Best Publications

  • A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B

    Ting Tsung Chang;Robert G. Gish;Robert De Man;Adrian Gadano

  • Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

    Ching Lung Lai;Daniel Shouval;Anna S. Lok;Ting Tsung Chang

  • Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

    Min Gao;Richard E. Nettles;Makonen Belema;Lawrence B. Snyder

  • Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

    Daniel J. Tenney;Ronald E. Rose;Carl J. Baldick;Kevin A. Pokornowski

  • Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine

    D J Tenney;S M Levine;R E Rose;A W Walsh

  • Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.

    Morris Sherman;Cihan Yurdaydin;Jose Sollano;Marcelo Silva

  • A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding

    Pin-Fang Lin;Wade Blair;Tao Wang;Timothy Spicer

  • Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.

    Robert G. Gish;Anna S. Lok;Ting Tsung Chang;Robert A. de Man

  • Entecavir resistance is rare in nucleoside naïve patients with hepatitis B.

    Richard J. Colonno;Ronald Rose;Carl J. Baldick;Steven Levine

  • Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound.

    Jie Wang;Tao Shen;Xiangbo Huang;G. Renuka Kumar

  • Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14.

    B Sherry;A G Mosser;R J Colonno;R R Rueckert

  • De Novo Initiation of RNA Synthesis by the RNA-Dependent RNA Polymerase (NS5B) of Hepatitis C Virus

    Guangxiang Luo;Robert K. Hamatake;Danielle M. Mathis;Jason Racela

  • Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.

    Ronald S. Veazey;Per Johan Klasse;Susan M. Schader;Qinxue Hu

  • cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1

    Joanne E. Tomassini;Donald Graham;Corrille M. Dewitt;Donald W. Lineberger

  • Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus.

    S F Innaimo;M Seifer;G S Bisacchi;D N Standring

  • A Dose-Ranging Study of the Efficacy and Tolerability of Entecavir in Lamivudine-refractory Chronic Hepatitis B Patients

    Ting–Tsung Chang;Robert G. Gish;Stephanos J. Hadziyannis;Janusz Cianciara

  • Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present

    Daniel J. Tenney;Ronald E. Rose;Carl J. Baldick;Steven M. Levine

  • Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions.

    Tao Wang;Zhongxing Zhang;Owen B. Wallace;Milind Deshpande

  • The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth.

    M Gao;L Matusick-Kumar;W Hurlburt;S F DiTusa

  • BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents

    Brett S. Robinson;Keith A. Riccardi;Yi-fei Gong;Qi Guo

Frequent Co-Authors

Nicholas A. Meanwell
Nicholas A. Meanwell Bristol-Myers Squibb (Germany)
Mark Krystal
Mark Krystal ViiV Healthcare (United Kingdom)
Man-Fung Yuen
Man-Fung Yuen University of Hong Kong
Guangxiang Luo
Guangxiang Luo University of Alabama at Birmingham
Pei-Yong Shi
Pei-Yong Shi GlaxoSmithKline (United Kingdom)
Robert G. Gish
Robert G. Gish University of Nevada Reno
Amiya K. Banerjee
Amiya K. Banerjee Cleveland Clinic Foundation
Jinlin Hou
Jinlin Hou Southern Medical University
Sang Hoon Ahn
Sang Hoon Ahn Yonsei University
Zachary Goodman
Zachary Goodman Inova Fairfax Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology offers a strong foundation for various health and science-related careers. Many students explore complementary online programs to broaden their skill sets and improve employability. For those interested in the administrative side of healthcare, pursuing a health information management bachelor degree salary can be a critical consideration when selecting a program. It highlights the financial benefits of this growing field.

If you’re looking for quality programs, the best online health information management degree cahiim accredited guide provides excellent insight into accredited options. Accreditation ensures the program meets professional standards and enhances career prospects.

For students interested in shorter, focused credentials, exploring the medical billing and coding certificate online accelerated programs can be valuable. These certificates offer a fast track into vital healthcare support roles, complementing microbiology knowledge.

Additionally, understanding the variety of online medical degrees available helps prospective students align their microbiology background with broader medical or health sciences careers. Online options increase accessibility and flexibility for continued education.

Best Scientists Citing Richard J. Colonno

Trending Scientists

Recently Published Articles